Experience With CMX001, a Novel Antiviral Drug, for Cytomegalovirus infections in Stem Cell Transplant Patients
Publication
, Conference
Papanicolau, G; Kurtzberg, J; Westervelt, P; Gea-Banacloche, J; Warlick, E; Lanier, R; Anderson, M; Painter, W
Published in: Biology of Blood and Marrow Transplantation
February 2011
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2011
Volume
17
Issue
2
Start / End Page
S273 / S274
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Papanicolau, G., Kurtzberg, J., Westervelt, P., Gea-Banacloche, J., Warlick, E., Lanier, R., … Painter, W. (2011). Experience With CMX001, a Novel Antiviral Drug, for Cytomegalovirus infections in Stem Cell Transplant Patients. In Biology of Blood and Marrow Transplantation (Vol. 17, pp. S273–S274). Elsevier BV. https://doi.org/10.1016/j.bbmt.2010.12.364
Papanicolau, G., J. Kurtzberg, P. Westervelt, J. Gea-Banacloche, E. Warlick, R. Lanier, M. Anderson, and W. Painter. “Experience With CMX001, a Novel Antiviral Drug, for Cytomegalovirus infections in Stem Cell Transplant Patients.” In Biology of Blood and Marrow Transplantation, 17:S273–74. Elsevier BV, 2011. https://doi.org/10.1016/j.bbmt.2010.12.364.
Papanicolau G, Kurtzberg J, Westervelt P, Gea-Banacloche J, Warlick E, Lanier R, et al. Experience With CMX001, a Novel Antiviral Drug, for Cytomegalovirus infections in Stem Cell Transplant Patients. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2011. p. S273–4.
Papanicolau, G., et al. “Experience With CMX001, a Novel Antiviral Drug, for Cytomegalovirus infections in Stem Cell Transplant Patients.” Biology of Blood and Marrow Transplantation, vol. 17, no. 2, Elsevier BV, 2011, pp. S273–74. Crossref, doi:10.1016/j.bbmt.2010.12.364.
Papanicolau G, Kurtzberg J, Westervelt P, Gea-Banacloche J, Warlick E, Lanier R, Anderson M, Painter W. Experience With CMX001, a Novel Antiviral Drug, for Cytomegalovirus infections in Stem Cell Transplant Patients. Biology of Blood and Marrow Transplantation. Elsevier BV; 2011. p. S273–S274.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2011
Volume
17
Issue
2
Start / End Page
S273 / S274
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences